富乐公司宣布收购先进医疗解决方案集团（AMS）。此项交易为一项推荐现金收购方案。
根据协议，AMS的股东将获得每股285便士的现金对价。该交易对AMS的股权估值约为6.59亿英镑，企业价值则达到约7.15亿英镑。
富乐公司预计，到2031年，此项收购将带来约5500万美元的年度协同效应。交易资金将通过已获得全额承诺的债务进行融资。
交易完成后，富乐公司的净杠杆率预计约为4.0倍。公司目标是在未来两年内，将净杠杆率降至2.5倍至3.0倍之间。
此外，在交易生效日，AMS的所有非执行董事均将辞去职务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.